174 related articles for article (PubMed ID: 24805933)
1. Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma.
Wu G; Lu X; Wang Y; He H; Meng X; Xia S; Zhen K; Liu Y
Int J Oncol; 2014 Jul; 45(1):351-61. PubMed ID: 24805933
[TBL] [Abstract][Full Text] [Related]
2. LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway.
Zhuang Z; Wang K; Cheng X; Qu X; Jiang B; Li Z; Luo J; Shao Z; Duan T
PLoS One; 2013; 8(7):e67431. PubMed ID: 23861764
[TBL] [Abstract][Full Text] [Related]
3. miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis.
Wu G; Liu H; He H; Wang Y; Lu X; Yu Y; Xia S; Meng X; Liu Y
BMC Cancer; 2014 Feb; 14():107. PubMed ID: 24552534
[TBL] [Abstract][Full Text] [Related]
4. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
5. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
6. Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells.
Cheng WT; Xu K; Tian DY; Zhang ZG; Liu LJ; Chen Y
Int J Oncol; 2009 Mar; 34(3):829-36. PubMed ID: 19212688
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
Li N; Yu Y; Wang B
Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog signaling pathway is inactive in colorectal cancer cell lines.
Chatel G; Ganeff C; Boussif N; Delacroix L; Briquet A; Nolens G; Winkler R
Int J Cancer; 2007 Dec; 121(12):2622-7. PubMed ID: 17683069
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling in human hepatocellular carcinoma.
Patil MA; Zhang J; Ho C; Cheung ST; Fan ST; Chen X
Cancer Biol Ther; 2006 Jan; 5(1):111-7. PubMed ID: 16397407
[TBL] [Abstract][Full Text] [Related]
11. Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations.
Galimberti F; Busch AM; Chinyengetere F; Ma T; Sekula D; Memoli VA; Dragnev KH; Liu F; Johnson KC; Guo Y; Freemantle SJ; Andrew AS; Greninger P; Robbins DJ; Settleman J; Benes C; Dmitrovsky E
Int J Oncol; 2012 Nov; 41(5):1751-61. PubMed ID: 22923130
[TBL] [Abstract][Full Text] [Related]
12. Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma.
Xu Y; Chenna V; Hu C; Sun HX; Khan M; Bai H; Yang XR; Zhu QF; Sun YF; Maitra A; Fan J; Anders RA
Clin Cancer Res; 2012 Mar; 18(5):1291-302. PubMed ID: 21868763
[TBL] [Abstract][Full Text] [Related]
13. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells.
Wu X; Zhao B; Cheng Y; Yang Y; Huang C; Meng X; Wu B; Zhang L; Lv X; Li J
Toxicol Appl Pharmacol; 2015 Oct; 288(1):74-83. PubMed ID: 26189965
[TBL] [Abstract][Full Text] [Related]
14. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.
Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H
Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma.
Tada M; Kanai F; Tanaka Y; Tateishi K; Ohta M; Asaoka Y; Seto M; Muroyama R; Fukai K; Imazeki F; Kawabe T; Yokosuka O; Omata M
Clin Cancer Res; 2008 Jun; 14(12):3768-76. PubMed ID: 18559595
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment.
Heller E; Hurchla MA; Xiang J; Su X; Chen S; Schneider J; Joeng KS; Vidal M; Goldberg L; Deng H; Hornick MC; Prior JL; Piwnica-Worms D; Long F; Cagan R; Weilbaecher KN
Cancer Res; 2012 Feb; 72(4):897-907. PubMed ID: 22186138
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line.
Werminghaus P; Haase M; Hornsby PJ; Schinner S; Schott M; Malendowicz LK; Lammers BJ; Goretzki PE; Müller-Mattheis V; Markus Giessing ; Willenberg HS
J Steroid Biochem Mol Biol; 2014 Jan; 139():7-15. PubMed ID: 24063979
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis.
Sicklick JK; Li YX; Jayaraman A; Kannangai R; Qi Y; Vivekanandan P; Ludlow JW; Owzar K; Chen W; Torbenson MS; Diehl AM
Carcinogenesis; 2006 Apr; 27(4):748-57. PubMed ID: 16339184
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma.
Ekin U; Yuzugullu H; Ozen C; Korhan P; Bagirsakci E; Yilmaz F; Yuzugullu OG; Uzuner H; Alotaibi H; Kirmizibayrak PB; Atabey N; Karakülah G; Ozturk M
J Gastrointest Cancer; 2021 Dec; 52(4):1356-1369. PubMed ID: 34738187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
